Diffuse Large B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Diffuse Large B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms [Phase 1]
A Phase 1 trial evaluating the combination of bortezomib and flavopiridol in patients with recurrent or refractory indolent B-cell neoplasms…
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: Trial to Define the Safety and Tolerability of SGN-40, Rituximab, and Gemcitabine in Patients With DLBCL [Phase 1]
A Phase 1 trial assessed the safety and tolerability of combining SGN-40 (dacetuzumab) with rituximab and gemcitabine in patients with diffu…
-
CLINICAL_TRIALS trial_result · 2014-12-09Clinical Trial Update: Assessment of Cellular Proliferation in Tumors by Positron Emission Tomography (PET) Using [18F]ISO-1 [Phase 1]
Phase 1 clinical trial update evaluating tumor cellular proliferation using the PET radiotracer [18F]ISO-1 in patients with breast cancer, h…
-
CLINICAL_TRIALS trial_result · 2014-12-09Clinical Trial Update: PTK787 in Refractory or Relapsed Diffuse Large Cell Lymphoma [Phase 2]
A Phase 2 trial of PTK787 (vatalanib) for refractory or relapsed diffuse large B-cell lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: Gemcitabine Hydrochloride, Cyclophosphamide, Vincristine Sulfate, Prednisolone, and Rituximab in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma [Phase 2]
Phase 2 clinical trial evaluating a gemcitabine hydrochloride–cyclophosphamide–vincristine sulfate–prednisolone–rituximab regimen in newly d…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-11-13Clinical Trial Update: Combination of SAR3419 and Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma [Phase 2]
This is a Phase 2 trial update on the combination of SAR3419 and rituximab in relapsed/refractory diffuse large B-cell lymphoma. The update …
-
CLINICAL_TRIALS trial_result · 2014-11-07Clinical Trial Update: RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors [Phase 1]
Phase 1 trial evaluating RO4929097 in combination with capecitabine in patients with refractory solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2014-11-04Clinical Trial Update: A Study of MabThera/Rituxan (Rituximab) in Patients With Relapsed Centroblastic Centrocytic Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 study of Rituximab (MabThera/Rituxan) in patients with relapsed centroblastic-centrocytic non-Hodgkin lymphoma has completed, with r…
-
CLINICAL_TRIALS trial_result · 2014-10-27Clinical Trial Update: Everolimus Plus Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma [Phase 2]
Phase 2 study evaluating everolimus plus rituximab in relapsed/refractory diffuse large B-cell lymphoma has completed, with results posted i…
-
CLINICAL_TRIALS trial_result · 2014-10-16Clinical Trial Update: Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma [Phase 3]
Phase 3 trial comparing Ofatumumab versus Rituximab salvage chemoimmunotherapy followed by autologous stem cell transplant in relapsed or re…
-
CLINICAL_TRIALS trial_result · 2014-10-08Clinical Trial Update: Pilot Study of dMRI as a Tool for Early Evaluation of Tumor Response in Diffuse Large B-cell Lymphoma
Pilot study evaluating diffusion MRI as a tool for early evaluation of tumor response in diffuse large B-cell lymphoma; the trial was termin…
-
CLINICAL_TRIALS trial_result · 2014-10-06Clinical Trial Update: Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]
This ClinicalTrials.gov update reports a terminated phase 1/2 trial evaluating fenretinide with rituximab for B-cell non-Hodgkin lymphomas; …
-
CLINICAL_TRIALS trial_result · 2014-09-30Clinical Trial Update: Dose Dense Chemotherapy and Rituximab for Young High Risk Diffuse Large B-Cell Lymphoma Patients (CRY-04) [Phase 2]
Completed Phase 2 clinical trial CRY-04 evaluating dose-dense chemotherapy with rituximab for young patients with high-risk diffuse large B-…
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: CT-011 MAb in DLBCL Patients Following ASCT [Phase 2]
Phase 2 trial results for the CT-011 monoclonal antibody in diffuse large B-cell lymphoma patients following autologous stem cell transplant…
-
CLINICAL_TRIALS trial_result · 2014-09-11Clinical Trial Update: Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL) [Phase 1, Phase 2]
Phase 1/2 safety and tolerability study of SNS01-T in relapsed or refractory B-cell malignancies sponsored by Senesco Technologies. The tria…
-
CLINICAL_TRIALS trial_result · 2014-09-05Clinical Trial Update: Rituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial results evaluating rituximab after autologous stem cell transplant in relapsed B-cell non-Hodgkin lymphoma have been completed…
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating agatolimod sodium in combination with rituximab and Yttrium-90 ibritumomab tiuxetan for adults with re…
-
CLINICAL_TRIALS trial_result · 2014-08-27Clinical Trial Update: Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia [Phase 1]
Phase 1 trial of vorinostat combined with decitabine in adults with advanced solid tumors or relapsed/refractory hematologic cancers, includ…
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma [Phase 2]
Phase 2 trial from the Children's Oncology Group assesses Rituximab, Rasburicase, and combination chemotherapy in children with newly diagno…
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: Study to Learn if 200mg Test Drug (Fostamatinib) Helps People With Large B-Cell Lymphoma,a Type of Blood Cancer [Phase 2]
Phase 2 trial evaluating fostamatinib 200 mg for diffuse large B-cell lymphoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: Comparison Study of Doxorubicin Versus Epirubicin-induced Cardiotoxicity in Patients With DLBCL [Phase 3]
A Phase 3 trial comparing doxorubicin and epirubicin in relation to cardiotoxicity in patients with diffuse large B-cell lymphoma has comple…
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) [Phase 2, Phase 3]
A trial update on lenalidomide for Diffuse Large B-Cell Lymphoma reporting completed phases 2 and 3 with results posted.
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: Dose-adjusted EPOCH-R in MYC Positive DLBCL [Phase 2]
A Phase 2 trial of dose-adjusted EPOCH-R for MYC-positive diffuse large B-cell lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-08-06Clinical Trial Update: Iodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous or Syngeneic Stem Cell Transplant for Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial update evaluating the combination of iodine-131 tositumomab with fludarabine phosphate in older patients undergoing autologous…
-
CLINICAL_TRIALS trial_result · 2014-07-30Clinical Trial Update: Ofatumumab and Bortezomib in Subjects With Relapsed CD20+Diffuse Large B Cell, Follicular, or Mantle Cell Lymphoma [Phase 2]
Phase 2 trial evaluating the combination of ofatumumab and bortezomib in adults with relapsed CD20-positive lymphomas, including diffuse lar…